Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep;49(9):1408-1413.
doi: 10.1038/ng.3921. Epub 2017 Jul 24.

Heterogeneity of Neuroblastoma Cell Identity Defined by Transcriptional Circuitries

Affiliations

Heterogeneity of Neuroblastoma Cell Identity Defined by Transcriptional Circuitries

Valentina Boeva et al. Nat Genet. .

Abstract

Neuroblastoma is a tumor of the peripheral sympathetic nervous system, derived from multipotent neural crest cells (NCCs). To define core regulatory circuitries (CRCs) controlling the gene expression program of neuroblastoma, we established and analyzed the neuroblastoma super-enhancer landscape. We discovered three types of identity in neuroblastoma cell lines: a sympathetic noradrenergic identity, defined by a CRC module including the PHOX2B, HAND2 and GATA3 transcription factors (TFs); an NCC-like identity, driven by a CRC module containing AP-1 TFs; and a mixed type, further deconvoluted at the single-cell level. Treatment of the mixed type with chemotherapeutic agents resulted in enrichment of NCC-like cells. The noradrenergic module was validated by ChIP-seq. Functional studies demonstrated dependency of neuroblastoma with noradrenergic identity on PHOX2B, evocative of lineage addiction. Most neuroblastoma primary tumors express TFs from the noradrenergic and NCC-like modules. Our data demonstrate a previously unknown aspect of tumor heterogeneity relevant for neuroblastoma treatment strategies.

Similar articles

See all similar articles

Cited by 41 articles

See all "Cited by" articles

References

    1. Development. 2010 Dec;137(24):4211-20 - PubMed
    1. Science. 1984 Jun 8;224(4653):1121-4 - PubMed
    1. Cell. 2013 Nov 7;155(4):934-47 - PubMed
    1. Nucleic Acids Res. 2015 Jul 1;43(W1):W50-6 - PubMed
    1. Nucleic Acids Res. 2012 Aug;40(15):e114 - PubMed

MeSH terms

Feedback